#Hcchat Hereditary Cancer Chat

Article

There will be another #Hcchat on Twitter this month with special guest Ellen Matloff.

There will be another #Hcchat on Twitter this month with special guest Ellen Matloff, MS, CGC entitled, "What About The Kids: Should We Test Children for Hereditary Cancer Syndromes?" Ellen Matloff, MS, CGC, will provide her expertise on this controversial topic. We hope you can join us.

Do you know about #Hcchat (Hereditary cancer chat) News? It’s a monthly newsletter put together by #Hcchat’s Amy Byer Shainman -- it’s a collaboration effort by all the top patients advocates for those with hereditary cancer syndromes to bring you all the latest news, blogs, books, clincial trial infomation and much more. Please find the link to it here.

Have you read the recent research regarding staying out of the sun?

According to a recent study published March 21 in the Journal of Internal Medicine, you may want to consider spending a little more time in the sun.

Researchers studied nearly 30,000 Swedish women and found that nonsmokers who stayed out of the sun had a similar life expectancy to smokers who basked in the sun. Contrary to popular belief, avoiding the sun is not a health benefit. Sunbathers not only lived longer but if they did develop cancer, they fought it better than those who avoided the sun. You may want to think about where you live, consider your country’s UV index and rethink the use of sunscreen.

And for those of you with Lynch syndrome and hereditary breast and ovarian cancer syndromes, here's some information on an upcoming conference:

Save the Date!

April 30, 2016, Conference on Hereditary Breast and Ovarian Cancer (HBOC) and Lynch syndrome (LS)

“Our fourth Beyond Risk conference for individuals with Hereditary Breast and Ovarian Cancer (HBOC) and Lynch syndrome (LS) will be held this spring! This is an event designed specifically for people affected by these conditions and their families. We will provide information and management updates promote early cancer detection and cancer risk-reduction. We also hope to have time for you to make connections with others so you can meet other families share your stories, and support one another."

Date: April 30, 2016

Time: 10:00 a.m. to 2:00 p.m. (Lunch will be provided.)

Location: The Fawcett Center, 2400 Olentangy River Rd., Columbus, OH 43210

Directions: http://www.fawcettcenter.com/page/directions

Check your mailboxes in the next few weeks for a registration brochure or contact us at genetics.clinic@osumc.edu for more information.” (via https://internalmedicine.osu.edu/genetics/patient-care/clinical-cancer-genetics)

Yours,

Georgia Hurst, MA

Founder and Executive Director of ihavelynchsyndrome.com

Twitter: @ShewithLynch

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content